共 53 条
[1]
Levy M.M., Fink M.P., Marshall J.C., Et al., SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Crit Care Med, 31, pp. 1250-1256, (2001)
[2]
Annane D., Bellissant E., Cavaillon J.M., Septic shock, Lancet, 365, pp. 63-78, (2005)
[3]
Martin G.S., Mannino D.M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med, 348, pp. 1546-1554, (2003)
[4]
Marshall J.C., The staging of sepsis: Understanding heterogeneity in treatment efficacy, Crit Care, 9, pp. 626-628, (2005)
[5]
Vincent J.L., Is the current management of severe sepsis and septic shock really evidence based?, PLoS Med, 3, (2006)
[6]
Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity, Cell, 124, pp. 783-801, (2006)
[7]
Knapp S., Wieland C.W., van 't Veer C., Et al., Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense, J Immunol, 172, pp. 3132-3138, (2004)
[8]
Wang X., Moser C., Louboutin J.P., Et al., Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung, J Immunol, 168, pp. 810-815, (2002)
[9]
Branger J., Knapp S., Weijer S., Et al., Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice, Infect Immun, 72, pp. 788-794, (2004)
[10]
Mollen K.P., Anand R.J., Tsung A., Et al., Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage, Shock, 26, pp. 430-437, (2006)